Conolidine’s analgesic results stem from its interaction with non-opioid pain pathways. In contrast to opioids, which bind to µ-opioid receptors while in the central nervous method, conolidine modulates alternate molecular targets. A Science Advances research found that conolidine interacts With all the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid https://popea197cfp7.wikienlightenment.com/user